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In vertebrates, extraembryonic tissues can act as
signaling centers that impose a reproducible pattern
of cell types upon the embryo. Here, we show that the
zebrafish yolk syncytial layer (YSL) secretes a ven-
tralizing signal during gastrulation. This activity is
mediated by Bmp2b/Swirl (Swr) expressed under
the control of Max’s giant associated protein (MGA)
and its binding partners, Max and Smad4. MGA
coimmunoprecipitates with both Max and Smad4 in
embryo extracts, and the three proteins form a
complex in vitro. Furthermore, all three proteins
bind to a DNA fragment upstream of the bmp2b
transcription start site. Targeted depletion of MGA,
its binding partners, or Bmp2b/Swr from the YSL
reduces BMP signaling throughout the embryo,
resulting in a mildly dorsalized phenotype. We
conclude that MGA, Max, and Smad4 act in the
extraembryonic YSL to initiate a positive feedback
loop of Bmp signaling within the embryo.
INTRODUCTION
The body plan of all multicellular organisms consists of a large
number of different cell types organized in the precise locations
necessary for the formation of functional tissues and organs.
This complex pattern of cell fates is communicated during
embryogenesis by specialized groups of cells called signaling
centers. In vertebrates, the first signaling centers form when
the extraembryonic lineages physically segregate from the rest
of the embryo (Bruce and Zernicka-Goetz, 2010). This occurs
in teleost fish when blastomeres at the embryo margin collapse
and release their contents into the adjacent yolk cell, forming a
syncytium called the yolk syncytial layer (YSL) (Kimmel and
Law, 1985). YSL nuclei remain in close proximity to embryonic
cells and are transcriptionally and mitotically active (Kane
et al., 1992). A series of classic yolk grafting and depletion exper-
iments demonstrated that signals emanating from the yolk cell
are necessary and sufficient to inducemesoderm and endoderm
(Chen and Kimelman, 2000; Mizuno et al., 1996; Oppenheimer,
1936). This function is highly conserved, because mammalian
and avian extraembryonic tissues have similar mesendoderm-322 Developmental Cell 28, 322–334, February 10, 2014 ª2014 Elsevinducing activities (Azar and Eyal-Giladi, 1981; Varlet et al.,
1997). Despite this work, it is not well understood how extraem-
bryonic tissues function as signaling centers. Although a number
of secreted factors are known to be expressed in extraembry-
onic tissues, the function of only a few of these molecules has
been determined (Fan et al., 2007). Furthermore, very little is
known about how the expression of any of these factors is
controlled during development.
In zebrafish, two members of the bone morphogenetic protein
(BMP) subclass of the TGF-b superfamily are expressed in the
YSL, but their function in this tissue is not understood. Within
the embryo, both bmp2b/swirl (swr) and bmp7a/snailhouse
(snh) are expressed in a graded fashion (Dick et al., 2000; Kishi-
moto et al., 1997; Schmid et al., 2000). Changes in the shape of
this gradient alter the dorsoventral body axis. Slight reductions
in BMP levels cause subtle expansions in dorsal cell types,
such as the neural plate, at the expense of ventral cell types,
such as the ventral tailfin (Kishimoto et al., 1997; Rentzsch
et al., 2006). When BMP levels are dramatically reduced, the
fates of all cells are transformed to the most dorsal cell type
(Schmid et al., 2000). There is also evidence that the BMP
gradient specifies different cell types at different times (Pyati
et al., 2005, 2006; Tucker et al., 2008). Blocking BMP signals
during gastrulation affects tissues in the anterior of the embryo,
such as the brain, whereas blocking BMP signals after gastrula-
tion affects posterior tissues, like the tail (Pyati et al., 2005;
Tucker et al., 2008).
Although the initiation of bmp gene expression is not well
understood, the maintenance of bmp expression is controlled
by an autoregulatory loop. BMP homodimers or heterodimers
bind to and activate a transmembrane complex containing two
type I and two type II receptor Ser/Thr kinases (Massague´
et al., 2005). The type I receptors phosphorylate the receptor
regulated Smad proteins (R-Smad), Smad1 and Smad5, which
form homodimers in the cytoplasm and associate with the com-
mon Smad (Co-Smad), Smad4. This complex translocates to the
nucleus where it activates transcription of target genes in asso-
ciation with various cofactors. In zebrafish, autoregulation of
the bmp genes depends upon Smad5, because expression of
bmp7a/snh and bmp2b/swr fails to be maintained in somitibun/
smad5 mutants (Hild et al., 1999; Schmid et al., 2000). In dorsal
regions, the secreted antagonist Chordin blocks BMP signaling
by binding extracellular BMP molecules and preventing them
from binding the receptors (Piccolo et al., 1996; Schulte-Merker
et al., 1997). This disrupts the autoregulatory pathway and bmp
expression is lost.ier Inc.
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MGA Controls Bmp ExpressionMax’s giant associated protein (MGA), also referred to as Max
gene associated, is the largest and least understood member of
the Max interacting network of transcription factors (Hurlin and
Huang, 2006; Hurlin et al., 1999). The defining structural feature
of this group is the presence of a basic helix-loop-helix zipper
(bHLHZip) domain that mediates both dimerization with Max
and sequence-specific binding to DNA at E-box sites (Grandori
et al., 2000). Max interacting proteins regulate growth and differ-
entiation in many contexts. For instance, Myc:Max heterodimers
activate transcription of a large number of target genes that pro-
mote progression through the cell cycle (Eilers and Eisenman,
2008). Other members of the Max interacting network promote
differentiation by sequestering Max, binding E-box sites, and re-
pressing transcription of Myc targets (Hurlin and Huang, 2006).
MGA antagonizes Myc in cell culture, and MGA:Max hetero-
dimers can be found as part of a larger transcription-silencing
complex on promoters of some cell-cycle genes (Ogawa et al.,
2002). Consistent with a role in controlling cell proliferation, mu-
tations in MGA are associated with a high risk of an aggressive
lymphoma called Richter’s Syndrome, which occurs in aminority
of patients with chronic lymphocytic leukemia (CLL) (De Paoli
et al., 2013; Chigrinova et al., 2013). MGA contains a second
DNA binding motif at its N terminus, a T-box domain of the
Tbx6 family (Hurlin et al., 1999; Lardelli, 2003). The T-domain
functions independently of the bHLHZip domain and mediates
binding to brachyury binding sites (Hurlin et al., 1999). Further-
more, MGA can either activate or inhibit transcription from
synthetic promoters (Hurlin et al., 1999). This suggests that
MGA activity depends upon its protein binding partners and its
context on the promoter. In zebrafish, MGA is expressed
maternally and zygotically and is required for development of
the brain, heart and gut (Rikin and Evans, 2010). Therefore, it is
an ideal candidate to regulate the expression of early signaling
molecules.
Our data indicate that a transcription factor complex com-
posed of MGA, Max, and Smad4 controls bmp2b/swr expres-
sion in the YSL, which in turn controls Bmp signaling in the
embryo. These results define a cell-cycle-independent function
for MGA and Max, acting in extraembryonic tissues to establish
and/or maintain the dorsoventral axis during gastrulation. In
addition to the other roles that have been established for MGA
in antagonizing Myc function, our results suggest a mechanism
for coordinating cell fate decisions with cell proliferation.
RESULTS
Zebrafish MGA Is an Essential Protein
The distribution of MGA protein during embryonic development
has not been previously characterized. There is a single mga
ortholog in the zebrafish genome, which encodes a predicted
protein of 2,735 amino acids with a calculated molecular weight
of 297.85 kDa (Lardelli, 2003; Rikin and Evans, 2010). Alignment
with human and mouse MGA protein sequences revealed three
regions of significant sequence homology outside the DNA bind-
ing domains (Figure 1A, green boxes). The conservation of these
regions over 400 million years of evolution implies that they are
important for MGA function, but the exact nature of their roles
is not known. mga mRNA migrated as a single 9 kb band on
Northern blots, but at least one exon, exon 14, was alternativelyDevelopmspliced (Figures 1B and 1C). Thus, there are at least two mga
transcripts at 4 and 6 hr postfertilization (hpf). Because exon
14 does not contain any obvious sequence motifs, it is not clear
if these variants are functionally different.
We raised antibodies directed against peptides from three
different regions of the protein: the N terminus, the C terminus,
or an internal fragment (Figure 1A, arrowheads). All three anti-
bodies recognized two bands, at 290 kDa and at 250 kDa
(Figure 1D and Figure S1A0 available online), consistent with pre-
vious reports that human MGA migrates as a doublet (Ogawa
et al., 2002). These bands were not present in gels probed
with preimmune serum (Figure 1D) and they were reduced in
mga morphants (Figure S1A). In fractionation experiments, the
large isoform segregated predominately to the nucleus while
the short isoform segregated predominately to the cytoplasm
(Figure 1E). In whole-mount immunofluorescence, MGA protein
was detected in the cytoplasm and nuclei of all cells of blastula
and gastrula stage embryos, including the yolk (Figures 1F–1P).
The signal is greatly reduced in embryos depleted of MGA
protein (Figure 1K). Interestingly, the anti-MGAI and anti-
MGAC antibodies detected protein predominantly in the cyto-
plasm (Figures 1G, 1I, 1L, 1M0, and 1N), while the anti-MGAN
antibody detected protein in both the nuclei and cytoplasm (Fig-
ures 1O and 1P). A Myc-tagged, C-terminal fragment of MGA
was also localized in both the cytoplasm and the nucleus (Fig-
ures 1Q and 1R).
We designed two translation-blocking morpholino oligonucle-
otides (MOs). mgaTL1MO and mgaTL3MO each nearly elimi-
nated the full-length MGA isoform, but were less effective
against the shorter isoform (Figure S1A). Both MOs generated
severe defects in embryos that were rescued by injection of
mouse mga mRNA (Figure S1J). At 24 hpf, mga morphants
were characterized by a shortened body axis, with reduced
midbrain, hindbrain, and trunk (Figures S1B and S1C). These de-
fects were similar in nature to those described in an earlier study
of mga function in zebrafish, but more severe (Rikin and Evans,
2010). This difference could be explained if our MOs were
more efficient than those used previously. In agreement with
the previous report, we conclude that mga is essential for the
proper development of many embryonic tissues.
The YSL Contains anmga-Dependent Ventralizing
Activity
We reasoned that depleting MGA from the YSL would circum-
vent the pleiotropic effects observed in whole embryo knock-
downs and permit us to determine the function of MGA in a
single tissue. The YSL is accessible to injection from the time
it forms until well after gastrulation, and it is possible to
knock down a gene’s function in this tissue without directly
impacting its activity in other cells (Chen and Kimelman, 2000;
Fan et al., 2007; Kimmel and Law, 1985). The vast majority of
embryos injected into the YSL with 4ng of either mgaTL1MO
or mgaTL3MO (mgaMO>YSL morphants) lacked the ventral
tailfin at the prim-5 stage (24 hpf) (Figures 2E, 2F, and S1K).
Similar results were obtained by coinjecting low doses (0.8 ng)
of both MOs simultaneously (data not shown), or by injecting
150 pg anti-MGA antibody into the YSL (Figures S1H and S1I).
mgaMO>YSL morphants were rescued by expressing either
mouse mga mRNA or zebrafish mga cDNA in the YSLental Cell 28, 322–334, February 10, 2014 ª2014 Elsevier Inc. 323
Figure 1. MGA Protein Is Maternally and Zygotically Expressed in All Cells
(A) Diagram of full-length MGA protein (top) or a C-terminal MGA fragment consisting of amino acids 2,058–2,735 (bottom). Arrowheads indicate the location of
the epitopes for anti-MGA antibodies. A conserved leucine rich nuclear export signal is shown. T-domain (residues 105–285), red; bHLHZip domain (residues
2,093–2,186), blue; Conserved Region 1 (CR1) (residues 938–1,166), CR2 (residues 1,260–1,370), CR3 (residues 2,540–2,715), green; Myc-epitope, black.
(B) Northern blot of 4 hpf and 6 hpf embryos for mga transcripts, using the probe indicated by the line in (A).
(C) RT-PCR of 8 hpf embryo extracts using primers anchored on either side of exon 14 (13F/15R), or internal to exon 14 (14FR). The lower (260 bp) band in lane 2
lacks exon 14; the upper bands (450 bp and 500 bp) contain exon 14. The 300 bp product in lane confirms the presence of exon 14.
(D) Western blot of 8 hpf embryo extracts showing specific bands at 290 kDa and 250 kDa.
(E) Western blot of cytoplasmic and nuclear extracts from 8 hpf embryos.
(F–P) Confocal images of MGA protein distribution. Embryos were counterstained with DAPI or nls-RFP as indicated, and the boundary between the YSL and
blastoderm is marked by a red line in (L), (M0 ), and (N).
(Q and R) Confocal images showing distribution of anti-Myc epitope in embryos injected with C-terminal MGA fragment shown in (A) or uninjected embryos;
counterstained with DAPI. Dorsal is to the right in (H), (I), (L), and (L0). At other stages there are nomorphological landmarks to determine the orientation. Scale bar
represents 50 mm.
See also Figure S3.
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MGA Controls Bmp Expression(Figure S1K). By contrast, the tailfin developed normally in all
embryos injected with control IgG antibodies or a 5 bpmismatch
MO (Figures 2A and 2B). This demonstrates thatmga is required
nonautonomously in the YSL to induce formation of the ventral
tailfin.
The loss of ventral tailfin in mga morphants is reminiscent of
the phenotype of zygotic acvr1l mutants, which lack the type I
BMP receptor, Alk8 (Mintzer et al., 2001). Therefore, we asked
whether mgaMO>YSL morphants had other defects character-
istic of reduced BMP signaling. Expression of the erythroid
marker gata1 was expanded into the posterior mesoderm in
the vast majority of mgaMO>YSL morphants at the 8-somite324 Developmental Cell 28, 322–334, February 10, 2014 ª2014 Elsevstage (Figures 2C and 2G). By contrast, pax2.1 expression,
which marks the pronephros and is normally present in the
posterior mesoderm, was unaffected (data not shown). Similar
defects are observed in bmp4 mutants and in embryos in which
BMP signaling is blocked after gastrulation (Pyati et al., 2006;
Stickney et al., 2007; Tucker et al., 2008). mgaMO>YSL mor-
phants also had heart defects (data not shown) and reduced
eve1 expression in the tailbud at the prim-5 stage (24 hpf) (Fig-
ures S1F and S1G), consistent with the requirement for BMP sig-
nals in these tissues (Pyati et al., 2005; Reiter et al., 2001). Finally,
the neurectoderm is slightly dorsalized in many morphants, as
indicated by an expansion of rhombomeres 3 and 5 (Figuresier Inc.
Figure 2. Extraembryonic MGA Controls
BMP Signaling in the Embryo
Embryos injected into the YSL with 4 ng of a 5 bp
mismatch control MO, mgamisMO (A–D, I, J) or
4 ng mgaTL3MO (E–H, K, L).
(A, B, E, and F) Livemorphants at the prim-5 stage.
(C and G) gata1 expression at the 8-somite stage.
(D and H) egr2b expression at the 8-somite stage.
(I and K) pSmad1/5 gradient at 75% epiboly. The
inset (I) shows the YSL nuclei are labeled with
nls-RFP.
(J and L) bmp2b/swr expression at 75% epiboly.
(M) Western blot of extracts of 75% epiboly
embryos. In mgaMO>YSL morphants, pSmad1:
48% ± 2.8%SD of controls and pSmad5: 53.5% ±
16.2% SD of controls. In acvr1lMO>1-cell mor-
phants, pSmad1: 25% ± 8.6% SD of controls and
pSmad5: 21.25% ± 4.7% SD of controls.
(N) Coimmunoprecipitation of HA-Smad4 with
pSmad1/5. HA-smad1 mRNA was injected into
the whole embryo at the 1-cell stage (lane 1) or into
the YSL at 3 hpf (lane 2). Anterior is to the left in
(A)–(H). Dorsal is to the right in (I)–(L). In all figures,
fractions indicate the number of embryos with the
depicted phenotype/total number injected.
See also Figures S1 and S2.
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MGA Controls Bmp Expression2D and 2H). These results are consistent with a reduction in BMP
signaling.
To determine if the BMP pathway is affected in mgaMO>YSL
morphants, we examined components of the BMP signal trans-
duction pathway. In control embryos at 75% epiboly (8 hpf), the
BMP antagonist chordin is expressed exclusively in dorsal cells
(Figure S2A). Levels of the BMP effector proteins, pSmad1 and
pSmad5 are high in ventral nuclei and low or absent in more
dorsal nuclei, reflecting the pattern of bmp2b/swr expression
(Figures 2I and 2J). pSmad5 levels are higher than those of
pSmad1, which is just beginning to be expressed (Figure 2M,
arrowheads) (Hild et al., 1999). Even though Smad5 is expressed
in the YSL in early embryos (Hild et al., 1999), we could not detect
pSmad1 or pSmad5 in YSL nuclei by immunofluorescence
(Figure 2I, inset). For a more stringent test of BMP signaling
activity, we expressed an HA-tagged version of Smad4 in the
whole embryo or only in the YSL. In coimmunoprecipitation ex-
periments, HA-Smad4 could not associate with either phosphor-
ylated Smad in the YSL but did associate with pSmad5 and, to a
lesser extent, pSmad1, when it was expressed in whole embryos
(Figure 2N). The absence pSmad1 or pSmad5 in the YSL indi-
cates that this tissue does not respond to BMP signals during
gastrulation.
In mgaMO>YSL morphants, expression of bmp2b/swirl (swr)
is reduced throughout the entire embryo at 75% epiboly (8 hpf),Developmental Cell 28, 322–334,including the YSL (Figures 2J and 2L),
and chordin expression is expanded
along the anterior-posterior axis (Figures
S2A and S2B, arrows). In addition,
the morphants have 50% the amount
of pSmad1/5 as control embryos
(Figure 2M). For comparison, mild
acvr1lMO>1-cell morphants, which re-semble mgaMO>YSL morphants, have 25% the amount of
pSmad1/5 as control embryos (Figure 2M) (Bauer et al., 2001).
In whole mounts, the pSmad1/5 gradient is visibly reduced and
shifted ventrally inmgaMO>YSLmorphants as compared to con-
trols (Figures 2I and 2K). Thus, loss ofmga function in the yolk cell
impairs BMP signaling in the embryo. This indicates that MGA in
the YSL acts to control expression of a ventralizing signal, which
in turn maintains the correct levels of bmp2b/swirl in the embryo.
Bmp2b/Swr Is a Required YSL Ventralizing Signal
To ask whether extraembryonic BMP signals are required for for-
mation of the ventral tailfin, we injected a previously character-
ized bmp2b/swrMO into the YSL (Imai and Talbot, 2001). Nearly
all the bmp2b/swrMO>YSL morphants lacked the ventral tailfin
at prim-5 (24 hpf) (Figures 3F and 3G). By contrast, embryos
injected into the YSL with a 5 bp mismatch control MO all devel-
oped normally (Figures 3A, 3B, and 3M). LikemgaMO>YSLmor-
phants, bmp2b/swrMO>YSL morphants displayed expanded
gata1 expression (Figures 3C and 3H), reduced eve1 expression
in the tailbud (Figures 3D and 3I), and had heart defects (data not
shown). In addition, the morphants were often dorsalized in
anterior regions, as indicated by a mild expansion the rhombo-
meres expressing egr2b (Figures 3E and 3J). During gastrulation,
the pSmad1/5 gradient was reduced and shifted ventrally
in bmp2b/swrMO>YSL morphants (Figures 3K and 3O), andFebruary 10, 2014 ª2014 Elsevier Inc. 325
Figure 3. MGA Acts Upstream of Bmp2b/
swr in the YSL
Embryos injected into the YSL with 1 ng of a 5 bp
mismatch control MO, bmpmis2b/swrMO (A–E
and K–M), or bmp2b/swrMO (F–J and O–Q).
(A, B, F, and G) Live morphants at the prim-5
stage.
(C and H) gata1 expression at the 8-somite stage.
(D and I) eve1 expression at the prim-5 stage.
(E and J) egr2b expression at the 8-somite stage
(12 hpf).
(K and O) pSmad1/5 gradient at 75% epiboly.
(L and P) bmp2b/swr expression at 75% epiboly.
(M) Tail region of prim-5 bmp2bmisMO>YSL
morphant, injected at shield stage.
(N) Western blot of 75% epiboly embryo extracts.
In acvr1lMO>1-cell morphants, pSmad1: 25% ±
8.6%SD of controls and pSmad5: 21.25%± 4.7%
SD of controls. In bmp2bMO>YSL morphants,
pSmad1: 18% ± 2.8% SD of controls and
pSmad5: 19% ± 2.8% SD of control levels.
(Q) Tail region of a prim-5 bmp2bMO>YSL mor-
phant, injection at shield stage.
(R and S) Live mgaMOTL3>YSL morphant at the
Long-pec stage (48 hpf), coinjected with 25 pg
b-galactosidase mRNA (R) or bmp2b mRNA (S).
(T) The presence (blue) or absence (red) of the
ventral tailfin was scored in mgaMOTL3>YSL
morphants injected with 25 pg b-galactosidase
mRNA or 25 pg bmp2b/swr mRNA and in
bmp2bMO>YSL morphants injected with 100 pg
b-galactosidase mRNA or 100 pg mouse mga
mRNA. Anterior is to the left in (A)–(C), (E)–(H), (J),
(M), and (Q)–(S) and up in (D) and (I). Dorsal is to the
right in (K), (L), (O) and (P). **p% 0.005.
See also Figure S2.
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MGA Controls Bmp ExpressionpSmad1/5 levels were one-fifth of the levels in control embryos
(Figure 3N). This reduction in pSmad1/5 levels was similar to
that observed in mild alk8 morphants. Expression of bmp2b/
swr was also reduced in bmp2b/swrMO>YSL morphants (Fig-
ures 3L and 3P), while chordin expression was expanded (Fig-
ures S2C and S2D, arrows). Therefore, bmp2b/swrMO>YSL
morphants strongly resembled mgaMO>YSL morphants by all
the morphological and molecular criteria we examined. This
raised the possibility that MGA controls bmp2b/swr expression
in the YSL. We next performed epistasis analysis to determine
if mga is required upstream of bmp2b/swr. Injection of 25 pg
bmp2b/swr mRNA into the YSL rescues the vast majority of
mgaMO>YSL morphants, whereas injection of b-galactosidase
mRNA has no effect (Figures 3R–3T). Conversely, injection of
mouse mga mRNA did not rescue bmp2b/swrMO>YSL mor-
phants (Figure 3T). These results demonstrate that MGA acts
upstream of Bmp2b/Swr and implicate Bmp2b/Swr as the
mga-dependent YSL ventralizing signal.
Two observations suggested that the YSL ventralizing signal
is required at later stages of embryogenesis. The dorsoven-
tral patterning defects we observed in mgaMO>YSL and
bmp2bMO>YSL, morphants strongly resembled those in which
BMP signaling was conditionally inactivated during late gastrula-
tion (Pyati et al., 2005; Tucker et al., 2008). In addition, bmp2b/
swirl and chordin expression in the morphants are aberrant at
in embryos at 75% epiboly (8 hpf), but are normal at earlier326 Developmental Cell 28, 322–334, February 10, 2014 ª2014 Elsevstages (data not shown). To determine when Bmp2b/Swr signals
in the YSL are required to specify the ventral tailfin, we injected
the bmp2b/swrMO into the YSL at shield stage (6 hpf). A signif-
icant fraction of late injected bmp2b/swrMO>YSL morphants
lacked the ventral tailfin at prim-5 (24 hpf), but embryos injected
with bmp2bmisMOs developed normally (Figures 3M and 3Q).
The MOs were much less effective than at earlier stages, prob-
ably because YSL morphology of late gastrula stage embryos
prevented rapid diffusion of the injected material (Y.S and
S.T.D, unpublished data). Nonetheless, our results indicate that
the ventralizing YSL signal is required during late gastrulation,
roughly consistent with the previously demonstrated temporal
requirements for BMP signaling (Connors et al., 2006; Pyati
et al., 2005; Tucker et al., 2008).
Zebrafish MGA Associates with Both Max and Smad4
Proteins during Gastrulation
Because the defining functional feature of mammalianMGA is its
ability to interact with Max, we performed yeast two-hybrid
assays to ascertain whether the zebrafish proteins could in-
teract. To facilitate our analysis, we dividedMGA into seven frag-
ments. A C-terminal fragment that included the bHLHZip and
CR3 domains was the only part of MGAwith the ability to interact
with Max (Figure S4A). To determine whether this interaction
could occur in physiological conditions, we injected mRNA en-
coding an HA-tagged version of Max into 1-cell stage embryosier Inc.
Figure 4. MGA Forms a Complex with Max and Smad4
(A) Coimmunoprecipitation of HA-Max (lanes 1–7) or endogenous Max (lanes 8–10) with endogenous MGA from extracts of embryos at 75% epiboly.
(B) Coimmunoprecipitation of HA-Smad4 (lanes 1–7) or endogenous Smad4 (lanes 8–10) with MGA from extracts of embryos at 75% epiboly.
(C) Coimmunoprecipitation of HA-Smad4 and Myc-MGACTD from extracts of embryos at 75% epiboly (lanes 1–4) or of transfected HEK293 cells (lanes 5–10).
(D) Sequential immunoprecipitation of in vitro translated Myc-MGACTD, HA-Smad4, and FLAG-Max, using anti-HA (round 1) and anti-Myc (round 2) antibodies.
(E) Coimmunoprecipitation of HA-Smad2MH2 with endogenous MGA from extracts of embryos at 75% epiboly (lanes 1–3). Sequential immunoprecipitation of
in vitro translated Myc-MGACTD, HA-Smad4MH2 and 35S-methionine-labeled FLAG-Max, using anti-HA (round 1) and anti-Myc (round 2) antibodies (lanes
4–11). Coimmunoprecipitation of in vitro translated Myc-CTDbHLHMGA and HA-Smad4 (lanes 12–14).
See also Figures S3 and S4.
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MGA Controls Bmp Expressionor into the YSL of older embryos. In both cases, anti-MGAN an-
tibodies pulled down MGA and HA-Max from embryo extracts,
whereas control antibodies pulled down neither protein (Fig-
ure 4A, lanes 1–7). In addition, anti-MGAN antibodies coimmu-
noprecipitated endogenous Max protein from extracts of
uninjected embryos (Figure 4A, lanes 8–10). This indicates that
Max can associate with MGA in embryos, including in the yolk
cell. Becausemax is coexpressedwithmga in the YSL of blastula
and gastrula stage embryos (Figures S3A–S3H), this interaction
could be functionally important.
A previous yeast two-hybrid screen identifiedMGAas a poten-
tial binding partner of Smad1 (Colland et al., 2004). In light of our
results implicatingMGAas a regulator of bmp2b/swr expression,
we performed yeast two-hybrid assays to test the seven MGA
fragments for potential interactions with all the Smad proteins.
The same C-terminal fragment that associated with Max also
interacted strongly with Smad4 and weakly with Smad1 and
Smad5 (Figure S4B). It did not interact with Smad2 or Smad3a.
Other fragments, including an N-terminal fragment that con-
tained the T-domain, did not interact with any Smad proteinsDevelopm(Figure S4B). To determine if MGA could interact with Smad4
under physiological conditions, we injected mRNA encoding
an HA-tagged version of Smad4 (HA-Smad4) into 1-cell stage
embryos or into the YSL of older embryos. In both cases, anti-
MGAI antibodies pulled down HA-Smad4 and endogenous
MGA (Figure 4B, lanes 1–7). In addition, anti-MGAI antibodies
pulled down endogenous Smad4 from uninjected embryos (Fig-
ure 4B, lanes 8–10). These results show that MGA and Smad4
physically associate with each other in embryos, including in
the yolk cell. Because smad4 is expressed in the YSL with mga
(Figures S3I–S3L), this interaction could be functionally relevant.
Our yeast two-hybrid results suggested that the C-terminal
677 amino acids of MGA are sufficient to interact with Smad4.
To test if this fragment also mediates the interaction under phys-
iological conditions, we coinjected mRNA encoding HA-Smad4
and mRNA encoding a Myc-tagged version of the C-terminal
MGA fragment (Myc-MGACTD; Figure 1A) into 1-cell stage em-
bryos. Alternately, we transfected both constructs into human
epithelial kidney (HEK) cells. Anti-Myc antibodies pulled down
both Myc-MGACTD and HA-Smad4 from embryo extracts andental Cell 28, 322–334, February 10, 2014 ª2014 Elsevier Inc. 327
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MGA Controls Bmp Expressionfrom extracts of transfected HEK cells (Figure 4C, lanes 1–7). In
the converse experiment, anti-HA antibodies pulled down both
proteins from HEK cell extracts (Figure 4C, lanes 8–10). Thus,
the C-terminal fragment is sufficient to mediate interactions
with Smad4.
Next, we asked if MGA could interact with other Smad pro-
teins, as suggested by our yeast two-hybrid results. We used a
reticulate lysate system to synthesize Myc-MGACTD and HA-
Smad5. We also synthesized HA-tagged versions of Smad5
and Smad4. When Myc-MGACTD and HA-Smad5 lysates were
mixed, anti-HA antibodies could pull down HA-Smad5, but not
Myc-MGACTD (Figure S4C). When Myc-MGACTD was ex-
pressed in embryos along with HA-Smad4, antibodies that
recognize the activated isoforms of both Smad1 and Smad5
(pSmad1/5), pulled down Smad5 and HA-Smad4, but not Myc-
MGACTD (Figure S4D). Finally, anti-Smad5 antibodies pulled
down endogenous Smad5 protein from embryo extracts, but
not endogenous MGA (Figure S4E). Taken together, our results
show that MGA can associate with both Max and Smad4 pro-
teins, but not with Smad5 or its activated isoform, and that a
fragment containing the bHLHZip domain is sufficient to mediate
these interactions.
Smad4 Binds MGA via a Mechanism that Permits
Formation of an MGA-Smad4-Max Complex
These results could be explained by two mutually exclusive
mechanisms. MGA could bind both proteins simultaneously to
form a trimeric complex, or binding of MGA to Smad4 could
prevent binding to Max, resulting in two populations of MGA
heterodimers. To distinguish between these possibilities, we
performed a sequential immunoprecipitation experiment on
in vitro synthesized Myc-MGACTD, HA-Smad4, and FLAG-
Max proteins. When HA-Smad4 and Myc-MGACTD lysates
were incubated together, anti-HA antibodies pulled down both
proteins, confirming they directly interact (Figure 4D, lane 2).
When HA-Smad4 lysates were incubated with FLAG-Max
lysates, anti-HA antibodies pulled down both HA-Smad4 and
FLAG-Max, showing that these two proteins also directly interact
(Figure 4D, lane 3). This is consistent with previous work showing
that the MH1 domain of Smad4 binds to the bHLHZip domain of
Max (Grinberg and Kerppola, 2003). As expected, anti-HA anti-
bodies pulled down HA-Smad4, Myc-MGA, and FLAG-Max
from samples containing all three proteins (Figure 4D, lane 4).
We eluted the precipitated complexes and subjected them to a
round of immunoprecipitation with anti-Myc antibodies. Sam-
ples containing all three proteins after the first round of precipi-
tation still contained all three proteins after the second round
(Figure 4D, lane 8). This would not be expected if the eluate
from the first round of immunoprecipitation contained two pop-
ulations of MGA heterodimers. We conclude that MGA, Max,
and Smad4 are present in a single complex.
This result was surprising because previous work had shown
that binding of Smad4 prevents Max from dimerizing with other
bHLHZip proteins (Grinberg and Kerppola, 2003). To understand
how Smad4 could simultaneously interact with two bHLHZip
proteins, we expressed a mutant version of Smad4 that lacks
the MH1 domain (called HA-Smad4MH2) in embryos. This pro-
tein lacks the MH1 domain and is not expected to interact with
Max. Anti-MGAI antibodies pulled down endogenous MGA and328 Developmental Cell 28, 322–334, February 10, 2014 ª2014 ElsevHA-Smad4MH2 protein from embryo extracts, but IgG anti-
bodies were ineffective (Figure 4E, lanes 1–3). Thus, the MH1
domain of Smad4 is dispensable for the association with MGA
in vivo. We next performed another sequential immunoprecipita-
tion experiment with in vitro translated proteins to determine
if the Smad4 MH1 domain was required for formation of
the trimeric complex. When lysates containing HA-Smad4MH2
were incubated with Myc-MGACTD lysates, anti-HA antibodies
pulleddownbothMyc-MGACTDandHA-Smad4MH2 (Figure 4E,
lane 5). This shows that the MH2 domain directly binds to MGA.
When HA-Smad4MH2 lysates were incubated with FLAG-Max
lysates, anti-HA antibodies could only pull downHA-Smad4MH2
(Figure 4E, lane 6). This confirms that theMH1 domain is required
for Smad4 to associate with Max, as previously reported (Grin-
berg and Kerppola, 2003). Anti-HA antibodies pulled down all
three proteins when all three proteins were incubated together
(Figure 4E, lane 7). The amount of Max protein precipitated
was close to the limit of detection by western blot and was better
visualized by incorporation of 35S-methionine. A second round of
immunoprecipitation with anti-Myc antibodies confirmed that
the three proteins were present in the same complex (Figure 4E,
lane 11). These results demonstrate that Smad4 utilizes the MH1
domain to interact with Max and the MH2 domain to bind MGA.
Much lessMax protein is present in the complex lacking theMH1
domain of Smad4 (compare Figure 4D, lane 8 with Figure 4E,
lane 11). This suggests that full-length Smad4 facilitates the
interaction between MGA and Max.
Because the bHLHZip motif of Max, MyoD and TFE3mediates
interactions with Smad3 and Smad4, we asked if the bHLHZip
domain of MGAwas required to associate with Smad4 (Grinberg
and Kerppola, 2003; Liu et al., 2001). We synthesized a
C-terminal fragment of MGA that lacks the bHLHZIP domain
(Myc-CTDbHLHMGA). Anti-Myc antibodies could pull down
Myc-CTDbHLHMGA, but not HA-Smad4 from lysates containing
either protein alone (Figure 4E, lanes 12 and 13). By contrast,
anti-Myc antibodies could pull down Myc-CTDbHLHMGAl
and HA-Smad4 from lysates containing both proteins (Figure 4E,
lane 14). Thus, the bHLH domain of MGA is not required for the
protein to associate with Smad4. This indicates that Smad4 in-
teracts differently with MGA than it does with other bHLHZIP
proteins.
Smad4 and Max Are Required in the YSL to Control Bmp
Signaling
If MGA, Max, and Smad4 form a complex under physiological
conditions, then Smad4 and Max may also be required in the
YSL to control BMP signaling, like MGA. To test this, we de-
signed translation-blocking MOs against both transcripts. The
maxMO reduced the level of Max protein in whole embryos (Fig-
ure S5M). Significant fractions of embryos injected into the YSL
with the maxMO or 150pg anti-Max antibody morphants lacked
the ventral tailfin at 24 hpf (Figures 5F, 5F0, 5U, S5D, and S5D0).
By contrast, embryos injected withmaxmisMO or IgG developed
normally (Figures 5A, 5A0, S5A, and S5A0). The ventral tailfin was
rescued by injecting HA-maxmRNA into the YSL (Figure 5U). At
earlier stages, expression of egr2b and gata1 are expanded in
maxMO>YSLmorphants and in anti-Max injected embryos while
eve1 is reduced in both cases (Figures 5G, 5H, S5G, and S5H).
Interestingly, rare morphants displayed an ectopic tailier Inc.
Figure 5. Smad4 and Max Are Required in
the YSL for BMP Signaling in the Embryo
Embryos injected into the YSL with 8 ng of
maxmisMO (A–E), maxMO (F–J), smad4misMO>
YSL (K–O), or smad4MO>YSL (P–T).
(A, A0, F, F0, K, K0, P, and P0) Image of a live mor-
phants at prim-5.
(B, G, L, and Q) egr2b expression at prim-5.
(C, H, M, and R) gata1 expression at 8-somites
(12 hpf).
(D, I, N, and S) pSmad1/5 gradient at 75% epiboly.
(E, J, O, and T) bmp2b/swr expression at 75%
epiboly.
(U) The presence (blue) or absence (red) of the
ventral tailfin was scored in smad4MO>YSL mor-
phants injected with 100 pg b-galactosidase
mRNA, 100 pg HA-smad4 mRNA, or 25 pg
bmp2b/swr mRNA. Tailfin defects (red) were also
scored in maxMO>YSL morphants injected with
100 pg b-galactosidase mRNA, 100 pg HA-max
mRNA, or 25 pg bmp2b/swr mRNA. Anterior is to
the left in (A)–(C), (F)–(H), (K)–(M), and (P)–(R).
Dorsal is to the right in (D), (E), (I), (J), (N), (O), (S),
and (T). *p% 0.05.
See also Figures S2 and S5.
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MGA Controls Bmp Expression(Figure S5H, arrowhead), a phenotype associated with late re-
ductions in Bmp levels (Pyati et al., 2005). These abnormalities
are not observed in maxmisMO>YSL morphants or embryos in-
jected with IgG (Figures 5B, 5C, S5B, S5C, and S5G). We ob-
tained similar results with the smad4MO, which was effective
in reducing Smad4 protein levels (Figure S5N). A significant
fraction of smad4MO>YSL morphants lacked the ventral tailfin
at 24 hpf (Figures 5P, 5P0, and 5U). Injection of HA-Smad4
mRNA into the YSL rescued the ventral tailfin defects in
smad4MO>YSLmorphants (Figure 5U). All 150 embryos injected
with a 5 bp mismatch control MO developed normally (Figures
5K and 5K0). At earlier stages, expression of egr2b and gata1
are expanded while eve1 is reduced (Figures 5Q, 5R, and S5J).
These abnormalities are not observed in smad4misMO>YSL em-
bryos (Figures 5L, 5M, and S5I). We conclude that both smad4
and max are required nonautonomously in the YSL to control
dorsoventral patterning, like mga.
The mild dorsalization of maxMO>YSL morphants and
smad4MO>YSL morphants was reminiscent of the defects in
embryos lacking bmp2b/swr in the YSL (Figure 3). Therefore,
we asked if BMP signaling was disrupted in the morphants.Developmental Cell 28, 322–334,bmp2b/swr expression is reduced in a
significant fraction of embryos injected
into the YSL with anti-Max antibodies
and in smad4MO>YSL morphants (Fig-
ures 5E, 5J, 5O, and 5T). chordin expres-
sion is often expanded along the anterio-
posterior axis in both maxMO>YSL and
smad4MO>YSL morphants (Figures
S2E–S2H, arrows). pSmad1 and pSmad5
levels were reduced as compared to con-
trols inmaxMO>YSL and smad4MO>YSL
morphants, although to a lesser extent
than in bmp2b/swrMO>YSL morphants(Figures S5K and S5L). The pSmad1/5 gradient was reduced
and shifted ventrally in a significant and reproducible fraction
of maxMO>YSL and smad4MO>YSL morphants (Figures 5D,
5I, 5N, and 5S). Finally, the ventral tailfin defects in both mor-
phants are rescued by injecting bmp2b/swr mRNA into the
YSL, but neither transcript rescued bmp2bswrMO>YSL mor-
phants (Figure 5U). This demonstrates that both Max and
Smad4 are required in the YSL upstream of bmp2b/swr expres-
sion, like MGA.
MGA, Smad4, and Max Interact Synergistically
If MGA, Max, and Smad4 are involved in the same genetic
pathway, then they should interact synergistically. To test this,
we injected suboptimal doses of smad4MO, maxMO, or anti-
Max antibodies into the YSL. The vast majority of embryos in-
jected with 1 ng smadMO or 100 pg anti-Max antibody alone
were indistinguishable from controls at prim-5 (24 hpf) (Figures
6A, 6D, 6G, and 6M). Out of 130 embryos with mildly impaired
Max or Smad4 in the YSL, 122 (93%) contained a normal ventral
tailfin (Figures 6B, 6E, and 6H). At earlier stages, the vast majority
of these embryos had normal egr2b and gata1 expressionFebruary 10, 2014 ª2014 Elsevier Inc. 329
Figure 6. MGA, Max, and Smad4 Are
Required Synergistically in the YSL
Embryos were injected into the YSL with subop-
timal doses of smad4misMO (A–F, M, and N) or
smad4MO (G–N) along with 100 pg of IgG (A, B, G,
H, and M), 100 pg anti-Max antibody (D, E, J, K,
and M), maxmisMO (C, I, M, and N),maxMO (F, L,
M, and N), and mgamisMO or mgaMO (N). One
nanogram each of MO was injected, except for
2 ng each of MO in (C), (F), (I), (L), and (N).
(A, B, D, E, G, H, J, and K) Images of live
morphants.
(C, F, I, and L) egr2b expression at 8-somites.
(M) Frequency of tailfin defects, expanded egr2b
expression or expanded gata1 expression (red).
(N) Embryos injected with 6 ngMO total (2 ng each
MO) and scored at Long-pec according to the
dorsoanterior index (Mullins et al., 1996). The key
is to the right, and representative embryos from
each class are depicted. Due to limited space, only
experimental MOs are listed on the x axis, but
in each case the applicable control MOs were
coinjected so that the total MO dose remained
constant.
See also Figure S5.
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MGA Controls Bmp Expression(Figure 6M). By contrast, when both Max and Smad4 are
reduced at the same time, 46% lacked the ventral tailfin (Figures
6J, 6K, and 6M). At younger stages, significant fractions had
mildly expanded egr2b or gata1 expression, reminiscent of that
observed inmgaMO>YSLmorphants (Figure 6M). This synergis-
tic interaction between Smad4 and Max indicates that both
genes cooperate in the YSL to specify the ventral tailfin, possibly
by acting in the same pathway.
When we injected higher doses (2 ng) of the smad4MO and
maxMO into the YSL, we observed a class of severely dorsalized
embryos. The fraction of embryos with expanded egr2b ex-
pression was the same whether Max and Smad4 were depleted
individually or together Figures 6F, 6I, and 6L). In the doublemor-
phants, however, the expansion of rhombomeres was often
more severe than observed in the single knockdowns. In seven
cases, egr2b expression extended around the entire circumfer-
ence of the embryo (Figure 6L). We next asked whether the
defects in 2 ng smad4MO + 2 ngmaxMO>YSLmorphants would
be further enhanced by reducing the level of MGA with 2 ng
mgaTL3MO. In this experiment, we scored live embryos at the
long-pec stage (48 hpf) for the amount of dorsalization according
to the dorso-anterior index (Mullins et al., 1996). As expected, the
vast majority of embryos with reduced Max or Smad4 in the YSL
developed normally (Figure 6N, blue bars). A distinct minority of
these embryos displayed the mildly dorsalized C1 phenotype
characterized by absence of the ventral tailfin (Figure 6N, red
bars). When levels of both Smad4 and Max were simultaneously
reduced, the frequency of embryos in the C1/C2 class rose to
slightly more than half (Figure 6N, red bars), confirming the
synergy between these two genes. In addition, a few embryos
displayed more severe, class C3/C4 defects (Figure 6N, yellow
bars). The frequency and severity of the dorsalized phenotypes
rose even further when levels of Max, Smad4, and MGA were
reduced. In this case, the majority of embryos displayed a
severely dorsalized class C3/C4 phenotype (Figure 6N, yellow
bars), while most of the remaining embryos were mildly dorsal-330 Developmental Cell 28, 322–334, February 10, 2014 ª2014 Elsevized (Figure 6N, red bars). A single embryo developed normally
(Figure 6N, blue bar). Because none of the MOs by themselves
completely eliminate the respective proteins, the severely dor-
salized phenotypes (Figures 6L and 6N) could result from a
greater loss of the MGA:Max:Smad4 complex in the multiple
knockdown embryos than occurs in any single or double mor-
phant. Alternately, the proteins may act separately, but have
redundant functions in controlling bmp2b/swr expression.
MGA, Max, and Smad4 Bind to Sites in the bmp2b
Regulatory Region
To determine if MGA could directly control bmp2b expression,
we screened the region upstream of the bmp2b transcription
start site for MGA binding by chromatin immunoprecipitation
(ChIP). Of five fragments containing consensus E-box se-
quences, only one fragment was significantly enriched for bound
MGA (Figure 7A). This fragment contained both a T-box binding
site and a Smad binding site in addition to the E-box site, raising
the possibility that MGA bound this site in association with Max
and Smad4 (Figure S5O). To test this, we performed a sequential
ChIP experiment. Fragments bound by MGA were eluted and
subjected to a second round of ChIP using anti-Smad4 anti-
bodies and a third round using anti-Max antibodies. At each
stage, the 3 kb fragment was significantly enriched compared
to an IgG control. After the third round, the fragment was en-
richedmore than 1,000-fold compared to the IgG control (Figures
7A and 7B). By contrast, a control fragment from the bmp2b/swr
coding regionwas not enriched in anyof theChIP rounds (Figures
7A and 7B). We conclude that MGA, Max, and Smad4 bind
together on the3 kb fragment, but not on the control sequence.
To test whether the three proteins can bind to DNA as a
complex, we performed an electromobility shift assay using a
35 bp probe containing the T-box, E-box, and Smad binding
sites from the bmp2b/swr promoter (Figure S5O, boxed
sequences). Nuclear extracts of HEK293 cells expressing
Myc-MGACTD, FLAG-Max, and HA-Smad4 contain two slowier Inc.
Figure 7. Models for MGA Function in
the YSL
(A) Sequential ChIP of a region 3.3 kb upstream of
the bmp2b transcriptional start site and another
region in the third exon of the bmp2b coding
region. ChIP 1, anti-MGAI; ChIP 2, anti-Smad4;
ChIP 3, anti-Max. Bars represent SD of technical
replicates.
(B) PCR products from the sequential ChIP
experiment in (A) were run on an agarose gel.
(C) EMSA using nuclear extracts of mock-trans-
fected HEK293 cells (lane 1), HEK293 cells trans-
fected with 5 mg each pCS2-Myc-MGACTD and
pCS2-FLAG-Max (lane 2), or HEK293 cells trans-
fected with 5 mg each pCS2-Myc-MGACTD,
pCS2-FLAG-Max, and pCS2-HA-Smad4 (lanes
3–9). The extracts used in lanes 1–5 and the
extracts used in lanes 6–9 were from independent
transfections, which accounts for differences in
the intensities of some bands.
(D) Our favored model in which a complex con-
taining MGA, Max, and Smad4 binds to the
bmp2b/swr promoter in the YSL and stimulates
transcription. MGA, purple oval; Max, red circle;
Smad4, green dumbbell.
See also Figure S5.
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MGA Controls Bmp Expressionmigrating complexes that bind to the probe (Figure 7C, lane 3).
Binding to the probe is effectively competed by addition of
excess unlabeled oligonucleotide, but not by a mutant oligonu-
cleotide with a 4 bp substitution that destroys the E-box (Fig-
ure 7C, lanes 4 and 5). This suggests that bHLHZIP-containing
proteins mediate binding of the complex to the probe. The com-
plexes are not present in nuclear extracts of untransfected cells,
indicating that they are composed of the exogenous proteins
(Figure 7C, lane 1). To test this, we included anti-Myc, anti-
FLAG, or anti-HA antibodies in the binding reaction. Each anti-
body supershifted the upper band and some of the lower band
(Figure 7C, lanes 6–9, compare red and black arrowheads).
Thus, Myc-MGACTD, FLAG-Max, and HA-Smad4 are present
in both complexes. We conclude that the upper band is bound
by a complex containing Myc-MGACTD, FLAG-Max, and HA-
Smad4 trimers, while the lower band is bound by a combina-
tion of Myc-MGACTD:FLAG-Max and FLAG-Max:HA-Smad4
heterodimers. Surprisingly, nuclear extracts of HEK293 cells
expressing only Myc-MGACTD and FLAG-Max also contained
a complex that comigrates with the probe bound to Myc-
MGACTD, FLAG-Max, and HA-Smad4 trimers (Figure 7C,Developmental Cell 28, 322–334,lane 2). This could be explained if Myc-
MGACTD and FLAG-Max recruit endoge-
nous Smad4 into a trimeric complex.
DISCUSSION
Bmp2b/Swr Signals in the YSL
Initiate an Autoregulatory Loop in
the Embryo
We have shown that MGA, Max, and
Smad4 act in the zebrafish YSL to control
expression of the ventralizing signal,Bmp2b/Swr. Our results support amodel in which these proteins
act in a complex to bind at least one enhancer region upstream
of the bmp2b/swr transcriptional start site (Figure 7D). More ex-
periments are needed to test the model, however. For instance,
we have not determined whether the sequence bound by MGA,
Max, and Smad4 in the bmp2b/swr locus is a functional
enhancer. Furthermore, we do not know if the MGA, Max, and
Smad4 complex forms in the YSL, although the proteins can
associate in the YSL when overexpressed. Finally, our results
do not indicate whether MGA directly controls bmp2b/swr
expression in other tissues after gastrulation, or whether it func-
tions as a Myc antagonist in embryos.
In our single morphants, BMP signals were reduced during
gastrulation and may decline further at later stages. This reduc-
tion is translated into defects after the tailbud stage, when BMP
signals act to specify the ventral tailfin cell fates (Connors et al.,
2006; Pyati et al., 2005; Tucker et al., 2008). Embryos lack the
ventral tailfin even when we injected bmp2bMOs into the YSL
at shield stage, ruling out a model in which BMP signals from
the YSL act early to establish BMP signals in the embryo and
are then dispensable. Conversely, multiple knockdown embryosFebruary 10, 2014 ª2014 Elsevier Inc. 331
Developmental Cell
MGA Controls Bmp Expressiondisplayed defects consistent with an early loss of BMP signals.
Thus, we conclude that Bmp2b/Swr signals from the YSL are
required continuously throughout gastrulation to induce or
maintain bmp2b/swr expression in the embryo and specify
ventral tailfin cell fates. This regulatory logic is similar to that re-
ported for Nodal signals during the blastula and early gastrula
stages (Fan et al., 2007; Hong et al., 2011). Both ndr1/sqt and
bmp2b/swr are expressed in highly dynamic tissues, with cell
positions constantly changing due to cell division and directed
movements. Despite this, the expression domains of these
genes remain relatively constant until after gastrulation, when
new expression domains appear that are independent of
autoregulatory signals from the YSL. We propose that the func-
tion of extraembryonic signals is to provide a stable point of
reference for the patterning of these dynamic tissues. In the
absence of extraembryonic signals, cell movements alone are
sufficient to disrupt the autoregulatory mechanisms. After
gastrulation, YSL signals decrease due to the loss of regulatory
factors in the YSL, and expression in the embryo is controlled by
other factors.
MGA and Max Control Cell Fate Decisions in a
Cell-Cycle-Independent Manner
MGA and Max proteins have well-described roles controlling
cell division, but our results indicate that they also act indepen-
dently of the cell cycle to control cell fate decisions. Both
proteins are transcription factors that act cell autonomously.
Max is the obligatory binding partner of Myc, and Myc-Max
heterodimers promote entry into the cell cycle at the level of
transcription (Eilers and Eisenman, 2008). By contrast, MGA
prevents entry to the cell cycle by sequestering Max and
antagonizing Myc activity (Grandori et al., 2000). MGA is also
present in complexes that mediate long-term repression of
cell-cycle control genes by modifying chromatin (Dou et al.,
2005; Ogawa et al., 2002). Therefore, it is possible that deple-
tion of MGA or Max activity effects Myc activity in the YSL,
resulting in YSL-specific cell-cycle defects. The defects we
observed, however, were in embryonic cells where MGA
and Max expression were unaffected and Myc activity was
normal. This indicates that MGA and Max have a function in
the YSL that is independent of any autonomous effect on the
cell cycle.
Our work differs from previous analyses of mga in one signif-
icant way. The embryos we examined were at early stages with
rapidly proliferating cells, whereas most previous studies on
mga were performed on established cell lines derived from
differentiated tissues, such as HEK293T cells and HeLa cells
(Dou et al., 2005; Hurlin et al., 1994; Ogawa et al., 2002). One
previous study of mga function was performed in an undifferen-
tiated cell line (Hu et al., 2009). Depletion ofmga caused prema-
ture differentiation of mouse embryonic stem cells. This is
inconsistent with a role for MGA promoting exit from the cell
cycle and consistent with our results indicating a cell-cycle-
independent function for MGA. This raises the possibility that
MGA has different roles at different developmental stages. It
may prevent differentiated cells from reentering the cell cycle
by antagonizing Myc activity and it may control the fate of plurip-
otent cells by regulating the expression of key signaling mole-
cules, such as BMP.332 Developmental Cell 28, 322–334, February 10, 2014 ª2014 ElsevEXPERIMENTAL PROCEDURES
Embryo Collection, Injection, and Staging
Embryos were obtained from single pair matings, raised 28.5C, and staged
according to Kimmel et al. (1995). YSL injections were performed as previously
described, including a fluorescent lineage tracer for verification of correct MO
targeting (Sun et al., 2011). In rescue experiments, separate injections were
performed to introduce the mRNA and MOs into the embryo, except when
the MOs did not target the transcript. During gastrulation, embryos were
staged based on their progress through epiboly. Embryos that failed to prog-
ress through epiboly were discarded. Development of the YSLmorphants was
delayed by <1 hr compared to controls, as determined by somite counts. To
compensate for this delay, we let experimental embryos develop an hour
longer than control injected embryos. Alternately, we staged fixed embryos
by morphology. All experiments were performed according to the Animal
Use Protocol (AUP) A2011 08-015, approved annually by the University of
Georgia IACUC committee.
Cloning Zebrafish MGA, Max, and Smad4 Genes
A BLAST search of the zebrafish genome revealed a T-box domain on Chro-
mosome 17. The sequence of the coding region was obtained from overlap-
ping clones of a cDNA library of 1–2 hpf embryos. The 50-end and 30-end of
the mga transcript were identified by RACE. Partial mga sequence was used
to identify ESTs EB991285 and EB931400 (Open Biosystems), which contain
most of the cDNA sequence. The full-length zebrafish smad4 cDNAwas ampli-
fied from a cDNA library from 8 hpf embryos. The full-length zebrafish max
cDNA was obtained from Genecopoeia (MGC: 55677 IMAGE: 381553).
Reagents
Sequences of all peptide and oligos generated for this work are provided in the
Supplemental Experimental Procedures. All blots were visualized using the
chemiluminescent western blot ECL substrate (Thermo Scientific). Sense tran-
scripts for injection were synthesized using the Ambion mMessage Machine
(Ambion). To synthesize the 9 kb mouse mga transcript, we added an extra
1 ml 20 mM guanosine triphosphate (GTP) to the reaction mix and increased
the reaction time to 4 hr.
RNA Analysis
For RT-PCR, Poly-A+ mRNA was isolated from embryos at 75% epiboly using
the Oligotex mRNA mini kit (QIAGEN) and reverse transcribed using the first
Strand cDNA Synthesis Kit (Thermo Scientific). For Northern blot, 15 mg
RNA extracted from 200 4 hpf or 6 hpf embryos (Invitrogen) was loaded on a
1% denaturing agarose gel and probed with a digoxigenin-labeled RNA
probe (nucleotides 5,920–7,430 of mga cDNA; Figure 1A) after transfer to a
Hybond-NX membrane (GE Healthcare). Bands were detected using the
chemiluminescent substrate for alkaline phosphatase, CSPD (Roche Applied
Sciences). WISH was carried out as previously described (Sun et al., 2011).
Following WISH, some embryos were prepared for plastic sections as previ-
ously described in Fan et al. (2007).
Protein Analysis
Proteins were translated using the TnT Quick coupled transcription/translation
system (Promega). We included 20 mg Ci 35S-methionine in the reaction to
radiolabel Max.
Immunofluorescence was performed as previously described (Sun et al.,
2011). For both western blots and coimmunoprecipitation assays, protein ex-
tracts of 100, deyolked embryos at 75% epiboly were prepared as described
(Sun et al., 2011), quantified by Bradford assay and 15 mg protein was loaded in
each lane. Coimmunoprecipitation was performed with the Pierce Coimmuno-
precipitation Kit according to the manufacturer’s instructions, using 100 ml
column resin conjugated to 100 mg anti-MGA antibody, 100 mg anti-Myc anti-
body, or 100 mg IgG.
Sequential ChIP was performed in biological and technical duplicate using
the Re-ChIP-IT Magnetic Chromatin Re-Immunoprecipitation Kit (Active
Motif). For each biological duplicate, 5,000 embryos were collected at 75%
epiboly over a period of 3 weeks. Chromatin was prepared immediately
and stored at 70C until ChIP. Following Chip, quantitative real-time PCR
was performed in a BioRad Cycler using the SYBR Green method. Briefly,ier Inc.
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MGA Controls Bmp Expressionchromatin was precipitated first with anti-MGAI (ChIP 1). After elution, precip-
itated chromatin was subjected a round of ChIP using anti-Smad4 antibodies
(ChIP 2) and the process was repeated for a third round of ChIP using anti-Max
antibodies (ChIP 3). At each step, an aliquot of precipitate was subjected to
quantitative real-time PCR and run on a gel. The fold enrichment was calcu-
lated and reported relative to the amount of input chromatin. Results pre-
sented are from one experiment.
For electrophoretic mobility shift assay (EMSA), 53 106 HEK293T cells were
transfected with a total of 15 mg plasmid DNA, including 5 mg pCS2-Myc-
MGACTD, 5 mg pCS2-FLAG-Max, and/or 5 mg pCS2-HA-Smad4 with an
appropriate amount of pCS2 plasmid to make up the balance. Three micro-
grams of nuclear extract protein was incubated with 1 pmol double-stranded,
50-biotinylated probe in binding buffer for 25 min and separated in a 6% gel in
0.53 TBE. In some reactions, 100-fold excess unlabeled wild-type or mutant
probe, or 1 mg anti-Myc antibody, anti-FLAG, anti-HA, or IgG was added to
the reaction.
Statistical Analysis
The paired t test (one-tailed) was used to determine the significance of all
rescue experiments and the sequential ChIP experiment.
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